School of Medicine
Showing 111-120 of 928 Results
-
David Larson
Professor of Radiology (Pediatric Radiology)
BioDavid B. Larson, MD, MBA, is Professor of Radiology (Pediatric Radiology) and Executive Vice Chair in the Department of Radiology at Stanford University. He also serves as the Associate Chief Quality Officer for Improvement for Stanford Health Care, overseeing improvement training programs at SHC. Dr. Larson is a national thought leader in radiology quality improvement and patient safety, and a regular speaker regarding topics ranging from pediatric CT radiation dose optimization to radiology peer learning. He is the founder of Stanford’s Realizing Improvement through Team Empowerment (RITE) program and co-founder of the Clinical Effectiveness Leadership Training (CELT) program, continuing to serve as co-executive director of both programs. He also founded and leads the Stanford Medicine Improvement Capability Development Program (ICDP) and the Advanced Course in Improvement Science (ACIS).
Dr. Larson is the founder and program chair for the annual Radiology Improvement Summit held annually at Stanford, which began in 2015. He currently serves on the Board of Trustees of the American Board of Radiology, overseeing quality and safety, and on the Board of Chancellors for the American College of Radiology as the chair of the ACR's Commission on Quality and Safety. He also founded and leads the ACR Learning Network, which was launched in 2021.
Prior to his position at Stanford, Dr. Larson was the Janet L. Strife Chair for Quality and Safety in Radiology and a faculty member of the James M. Anderson Center for Health Systems Excellence at Cincinnati Children’s Hospital in Cincinnati, Ohio. He holds MD and MBA degrees from Yale University and completed his training at the University of Colorado Health Sciences Center in Denver, Colorado. Dr. Larson is a pediatric radiologist at Lucile Packard Children's Hospital at Stanford. He and his wife, Tara, live in Portola Valley, California and have four children. -
Wesley Brian Lashbrook, MSPA, MPH, PA-C
Clinical Instructor (Affiliated), School of Medicine - Senior Associate Dean for Medical Student Education
BioWesley Lashbrook is a Family Medicine clinician who sees children and adults. He has a background in public health with a focus on community preventative health, disease prevention, and chronic disease management. Originally from Oregon, Wesley has lived in the Bay Area for 10 years. He enjoys cooking, reading, running, and hiking.
-
Ruth Lathi, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Current Research and Scholarly InterestsRecurrent miscarriage, genetic and other causes of miscarriage, preimplantation genetic diagnosis, effects of fertility treatments on androgen levels in early pregnancy and how fertility diagnosis and treatments affect pregnancy outcomes.
-
Amira Latif Hernandez
Instructor, Neurology & Neurological Sciences
BioAmira obtained her Ph.D. in Neuroscience from the KU Leuven, Belgium, in summer 2017. During her doctoral studies, she used clinically valid tests of murine cognition, neuronal plasticity measures in hippocampal and cortical slices, brain lesion methods, pharmacological applications and resting state functional magnetic resonance imaging to characterize the pathophysiology of novel mouse models of Alzheimer’s disease (AD). One of her most gratifying contributions was the development of a new electrophysiology tool to assess synaptopathies, and the establishment of long-term synaptic plasticity from prefrontal cortex of APP knock-in mice. In Autumn 2017, she moved to Dr. Longo’s lab at the Stanford School of Medicine, where she investigates signaling pathways involved in synaptic degeneration. During 3 years of postdoctoral work, she established a multi-electrode array system with eight independent recording chambers that allows high-throughput analyses of multiple long-lasting forms of synaptic plasticity. She also gained experience in RNA-sequencing, molecular biochemistry, signaling mechanisms, target validation and drug development strategies for AD. In October 2020, Amira has been appointed as an Instructor in Neurodegenerative Disease Research, in the Longo lab, to help develop improved and more powerful approaches that will better reveal key synaptic mechanisms and candidate modules associated with neuroplasticity and affected in AD mouse models, by identifying activity-dependent gene expression signatures.
